Ekotoxikologické centrum Bratislava, spol. s r.o.

REACH
EN
  • Online Registrations

OZNAM

ATTENTION! Karty bezpečnostných údajov31 May 2018 is the final deadline for substances in range of 1 - 100 tonnes per year. Remaining time:
FacebookTwitterGoogle

Actual info

The impact of the 11th adaptation on technical and scientific progress

Draft 11-tej adaptácie na technický a vedecký pokrok (ATP) nariadenia CLP/GHS (Nariadenie (EC) č. 1272/2008) bol zverejnený a zaslaný na pripomienky Svetovej obchodnej organizácii.

Read more...
SECTION 4: First aid measures

Informations are provided from COMMISSION REGULATION (EU) No 453/2010 of 20 May 2010 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

This section of the safety data sheet shall describe the initial care in such a way that it can be understood and given by an untrained responder without the use of sophisticated equipment and without the availability of a wide selection of medications. If medical attention is required, the instructions shall state this, including its urgency.

4.1. Description of first aid measures

4.1.1. First aid instructions shall be provided by relevant routes of exposure. Subdivisions shall be used to indicate the procedure for each route, such as inhalation, skin, eye and ingestion.

4.1.2. Advice shall be provided as to whether:

  • (a) immediate medical attention is required and if delayed effects can be expected after exposure;
  • (b) movement of the exposed individual from the area to fresh air is recommended;
  • (c) removal and handling of clothing and shoes from the individual is recommended; and
  • (d) personal protective equipment for first aid responders is recommended.

4.2. Most important symptoms and effects, both acute and delayed
Briefly summarised information shall be provided on the most important symptoms and effects, both acute and delayed, from exposure.

4.3. Indication of any immediate medical attention and special treatment needed
Where appropriate, information shall be provided on clinical testing and medical monitoring for delayed effects, specific details on antidotes (where they are known) and contraindications.
For some substances or mixtures, it may be important to emphasise that special means to provide specific and immediate treatment shall be available at the workplace.

 

ECHA substances (click):

Pre-registered substances Registered substances

Navigator
Substances of Very High Concern identification